Immunomodulatory activity of curcumin-entrapped poly d, l-lactic-co-glycolic acid nanoparticles in mice FID Afolayan, B Erinwusi, OT Oyeyemi Integrative medicine research 7 (2), 168-175, 2018 | 83 | 2018 |
Machine learning–based hyperglycemia prediction: enhancing risk assessment in a cohort of undiagnosed individuals K Oyebola, F Ligali, A Owoloye, B Erinwusi, Y Alo, AZ Musa, O Aina, ... JMIRx Med 5 (1), e56993, 2024 | 4 | 2024 |
Assessing the therapeutic efficacy of artemether-lumefantrine for uncomplicated malaria in Lagos, Nigeria: a comprehensive study on treatment response and resistance markers KM Oyebola, FC Ligali, AJ Owoloye, OO Aina, YM Alo, B Erinwusi, ... Malaria Journal 23 (1), 261, 2024 | 2 | 2024 |
Machine learning insights on the effectiveness of non-pharmaceutical interventions against COVID-19 in Nigeria KM Oyebola, FC Ligali, AJ Owoloye, BD Erinwusi, AZ Musa, OO Aina, ... International Health, ihae065, 2025 | | 2025 |
Authors’ Response to Peer Reviews of “Machine Learning–Based Hyperglycemia Prediction: Enhancing Risk Assessment in a Cohort of Undiagnosed Individuals” K Oyebola, F Ligali, A Owoloye, B Erinwusi, Y Alo, AZ Musa, O Aina, ... JMIRx Med 5, e60174, 2024 | | 2024 |
PA-762 Prevalence of Pfcrt K76T mutation years after chloroquine withdrawal in Lagos, Nigeria F Ligali, A Owoloye, J Akinola, Y Alo, M Okorigwe, B Erinwusi, O Aina, ... BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
PA-107 Efficacy status of artemisinin-based combination treatment of falciparum malaria in Lagos, Nigeria K Oyebola, F Ligali, A Owoloye, O Aina, Y Alo, B Erinwusi, M Olufemi, ... BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
Assessing the Therapeutic E cacy of Artemether-Lumefantrine for Uncomplicated Malaria in Lagos, Nigeria: A Comprehensive Study on Treatment Response and Resistance Markers KM Oyebola, FC Ligali, AJ Owoloye, OO Aina, YM Alo, B Erinwusi, ... | | |